drugset / Trial / NCT01961947
Study of ASP7374, Cell-culture-derived Influenza Vaccine
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to compare immunogenicity and safety of ASP7374 (cell-culture derived influenza vaccine) with those of approved egg-derived trivalent inactivated vaccine (TIV) in adults ≥20 and \<65 years.
Timeline
- Start
- 2013-10
- Primary completion
- 2013-11
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASP7374 | Vaccine | — | Subcutaneous |
| Comparator | TIV | Vaccine | — | Subcutaneous |